These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4627410)

  • 1. Unproven methods of cancer management.
    CA Cancer J Clin; 1972; 22(5):312-7. PubMed ID: 4627410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical results in cancer patients treated with an original technic of active immunotherapy].
    Alem C
    Boll Ist Sieroter Milan; 1971; 50(4):260-7. PubMed ID: 5163493
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic management of cancer].
    Unsgård G
    Tidsskr Nor Laegeforen; 1981 Aug; 101(24):1322-6. PubMed ID: 6457419
    [No Abstract]   [Full Text] [Related]  

  • 4. About human tumor antigens to be used in immunotherapy.
    Lucas S; Coulie PG
    Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunology at the service of cancer immunotherapy.
    Finn OJ
    Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cells in cancer immunotherapy - a short review.
    Wojas K; Tabarkiewicz J; Roliński J
    Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unproven methods of cancer management. Issels combination therapy.
    CA Cancer J Clin; 1972; 22(3):188-91. PubMed ID: 4339809
    [No Abstract]   [Full Text] [Related]  

  • 9. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
    Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
    Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer immunotherapy: immunologic bases, reality and hopes].
    Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
    Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigens for cancer immunotherapy.
    Neller MA; López JA; Schmidt CW
    Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unproven methods of cancer management. Immuno-augmentative therapy.
    CA Cancer J Clin; 1984; 34(4):232-7. PubMed ID: 6430483
    [No Abstract]   [Full Text] [Related]  

  • 13. Targets for active immunotherapy against pediatric solid tumors.
    Jacobs JF; Coulie PG; Figdor CG; Adema GJ; de Vries IJ; Hoogerbrugge PM
    Cancer Immunol Immunother; 2009 Jun; 58(6):831-41. PubMed ID: 19009292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical increment of Lewis blood group antigen in serum by cancer found by photothermal immunoassay.
    Kimura H; Kitamori T; Sawada T
    Anal Biochem; 1999 Oct; 274(1):98-103. PubMed ID: 10527501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis (CT) antigens: potential targets for immunotherapy.
    Caballero OL; Chen YT
    Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific active immunotherapy of cancer].
    Valladares Y
    An R Acad Nac Med (Madr); 1982; 99(1):109-46. PubMed ID: 6181704
    [No Abstract]   [Full Text] [Related]  

  • 17. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unproven methods of cancer management. Part II: Current trends and implications for patient care.
    Howard-Ruben J; Miller NJ
    Oncol Nurs Forum; 1984; 11(1):67-73. PubMed ID: 6318190
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
    Chatterjee M; Draghici S; Tainsky MA
    Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.